Fetal basis of childhood and adult disease: role of the environment. (Extramurally Speaking ...).It is recognized that between 2% and 5% of all live-born infants have a structural (birth) defect. Approximately 40% of these defects, although of unknown etiology, are thought to be due to the effects of adverse exposure(s) of the embryo/fetus to intrauterine intrauterine /in·tra·uter·ine/ (-u´ter-in) within the uterus. in·tra·u·ter·ine adj. Within the uterus. Intrauterine Situated or occuring in the uterus. environmental factors. In addition, 10% of all births occur prematurely, accounting for 75% of early postnatal postnatal /post·na·tal/ (-na´t'l) occurring after birth, with reference to the newborn. post·na·tal adj. Of or occurring after birth, especially in the period immediately after birth. death and 50% of all long-term handicaps. Exposure to environmental agents during development can result not only in the death of the embryo/fetus, structural (birth) defects, and altered growth but also in functional changes in tissues and organ systems that appear normal but have altered functional potential. A growing body of evidence indicates that such subtle functional defects can lead to childhood--adult morbidity and/or mortality because of the altered fetal programming of tissues, organs, and/or systems during development. Although the mechanism of permanent fetal programming is unknown, evidence suggests that the induced effect can be transgenerational. The advent of the powerful new technologies of genomics, proteomics, and bioinformatics has opened the avenue to detailed explorations of the underlying mechanism(s) of the fetal programming process from initial exposure(s) to the consequent health outcome. Epidemiologic studies have shown that low birth weight at term and, more specifically, intrauterine growth retardation Intrauterine Growth Retardation Definition Intrauterine growth retardation (IUGR) occurs when the unborn baby is at or below the 10th weight percentile for his or her age (in weeks). are associated with insulin resistance Insulin Resistance Definition Insulin resistance is not a disease as such but rather a state or condition in which a person's body tissues have a lowered level of response to insulin, a hormone secreted by the pancreas that helps to regulate the level , type 2 diabetes mellitus Type 2 diabetes mellitus One of the two major types of diabetes mellitus, characterized by late age of onset (30 years or older), insulin resistance, high levels of blood sugar, and little or no need for supple-mental insulin. , hypertension, coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. , and lowered cognitive performance. In these studies, low birth weight at term was due to severe malnutrition during pregnancy. Preliminary data show that functional changes similar to those seen with severe malnutrition may occur with in utero exposures to environmental agents. Indeed, exposure to environmental agents in utero can alter gene expression, and some of these changes are permanent. Thus, altered genetic programming may have the potential to lead to increased susceptibility to reproductive, cardiovascular, or nervous system diseases. In February 2002, the National Advisory Environmental Health Sciences Council approved a concept for initiative development in the area of the fetal origin of adult disease. The NIEHS NIEHS National Institute of Environmental Health Sciences (NIH, DHHS) is developing a program that recognizes the growing concern that exposures to environmental factors, either in utero alone or in combination with childhood exposures, may predispose pre·dis·pose v. To make susceptible, as to a disease. individuals to childhood- or adult-onset diseases. Initiatives coming out of this program may be found at http://www.niehs.nih.gov/dert/home.htm. Elucidating the underlying mechanism of such susceptibilities may allow risk reduction via public health intervention/prevention efforts. Contacts: Jerry Heindel, Ph.D. | e-mail heindelj@niehs.nih.gov J. Patrick Mastin, Ph.D. | email mastin@niehs.nih.gov Annette Kirshner, Ph.D. | email kirshner@niehs.nih.gov |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion